Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Neurotoxicology. 2013 Aug 2;38:131–135. doi: 10.1016/j.neuro.2013.07.002

Table 2.

Brain Harmane Concentrations in Study Subjects

ET (n=70) Geometric mean (95% CI) Controls (n=27) Geometric mean (95% CI) P-value
Unadjusted 0.9950 (0.8578, 1.1541) 0.9108 (0.7933,1.0456) 0.38
Unadjusteda 1.0025 (0.8630 – 1.1645) 0.8938 (0.7716 – 1.0353) 0.27
Covariate Adjusteda,b 1.0824 (0.9405 – 1.2457) 0.8037 (0.6967 – 0.9272) 0.004
ET + FH (n = 23) ET – FH (n=47) Controls (n = 27)
Unadjusted 1.0456 (0.7568, 1.4446) 0.9711 (0.8243, 1.1440) 0.9108 (0.7933,1.0456) 0.98
Unadjusteda 1.0731 (0.7680 – 1.4994) 0.9711 (0.8243 – 1.1440) 0.8938 (0.7716 – 1.0353) 0.96
Covariate Adjusteda,b 1.2005 (0.8712 – 1.6541) 1.0312 (0.8879 – 1.1976) 0.8037 (0.6967 – 0.9272) 0.054

FH = family history of tremor.

a

Two controls with missing data on freezer time and one ET case with family history and missing data on PMI were excluded from the analysis.

b

Adjustment for PMI and freezer time.

p-value from t-test for difference between two groups and Kruskal-Wallis test for difference among three groups.